Expression landscape of the genetic hearing loss protein whirlin across human tissues and cell types.

This study presents the first comprehensive body-wide expression landscape of the genetic hearing loss protein whirlin by integrating multi-omics data, revealing its broad distribution across various human tissues and cell types beyond the inner ear and retina.

The Gist

The "Swiss Army Knife" of the Body: A New Map for the Whirlin Protein

Imagine your body is a massive, bustling city. For years, scientists knew about a specific construction worker named Whirlin (or WHRN). They knew he was the master builder of two very specific neighborhoods: the Inner Ear (where we hear) and the Retina (where we see). If Whirlin was missing or broken in these two spots, the city's residents would go deaf or blind. This was the only story we knew about him.

But this new research paper asks a simple question: "Is Whirlin only working in the ear and eye, or is he actually a city-wide employee?"

The answer is a resounding yes, he is everywhere. The researchers have created the first complete "map" of where Whirlin lives and works across the entire human body, and the results are surprising.

Here is the breakdown of their discovery, using some everyday analogies:

1. The "City-Wide" Discovery

Previously, we thought Whirlin was like a specialized mechanic who only fixed cars in a specific garage. This study shows he's actually a general contractor who is present in almost every district of the city (49 out of 51 tissues checked!).

• Where is he busiest? He is most active in the Endocrine District (hormone factories like the thyroid and adrenal glands), the Reproductive District, and the Nervous System (the brain and nerves).
• The Analogy: Think of Whirlin as a "scaffolding" protein. If your body is a building, Whirlin is the steel beams and scaffolding that hold things together. He helps organize the structure so that things (like hormones or signals) can move around efficiently.

2. The "Specialized Crew" (Single-Cell Analysis)

The researchers didn't just look at the whole city; they zoomed in to see exactly which workers were using Whirlin. They found that Whirlin isn't used by everyone equally.

• The Ciliated Crew: He is heavily used by cells that have tiny, hair-like whips called "cilia" (which help move fluids or sense the environment). This makes sense because his original job in the ear involved "stereocilia" (the tiny hairs that detect sound). Now we know he helps organize these hairs in the lungs, the reproductive tract, and even the brain.
• The Hormone Factories: He is very busy in cells that pump out hormones. It's like he's the foreman ensuring the conveyor belts in the hormone factories are running smoothly so the right packages get shipped out.
• The Immune Patrol: Even the immune system's soldiers (white blood cells) use him, though perhaps less intensively than the hormone factories.

3. The "Cancer Check-Up"

The team also checked if Whirlin goes haywire in cancer cells.

• The Finding: In most cancers, Whirlin behaves normally. It's like checking a factory that has been taken over by a criminal gang; the gang didn't bring in new equipment, they just kept using the existing machinery.
• The Exception: However, in some specific cancers (like lymphoma and colorectal cancer), Whirlin is very active. This suggests that in these specific "criminal gangs," the scaffolding might be helping the cancer cells grow or survive. This gives doctors a new potential target to study for treatments.

4. The "Lab Bench" Surprise

Finally, the researchers looked at the "test tubes" scientists use to study diseases (cell lines).

• The Surprise: They found that many standard lab cells (like the famous HeLa cells or kidney cells) naturally produce Whirlin.
• Why it matters: This is like finding out that the tools you need to fix a car are already sitting on your workbench. Scientists don't need to invent new tools to study Whirlin; they can use the cells they already have in their labs to figure out what else this protein does.

The Big Takeaway

For decades, we thought Whirlin was a one-trick pony, only good for hearing and vision. This paper pulls back the curtain to reveal that Whirlin is a fundamental structural protein that helps organize cells all over the body.

Why should you care?
If Whirlin helps organize cells in the brain, the gut, and the hormone glands, then mutations in the Whirlin gene might be linked to more than just deafness. It could be a hidden player in:

• Thyroid issues.
• Neurological disorders (like bipolar disorder or schizophrenia).
• Digestive problems.

This study is like finding the missing piece of a puzzle. It tells us that the "hearing loss protein" is actually a "body organization protein," opening the door to understanding many other diseases we didn't realize were connected.

Technical Summary

1. Problem Statement

Whirlin (WHRN/DFNB31) is a well-characterized cytoskeletal scaffolding protein essential for the development and function of sensory cells in the inner ear (stereocilia) and retina (photoreceptors). Mutations in WHRN cause autosomal recessive non-syndromic hearing loss (DFNB31) and Usher syndrome type 2. While its role in sensory systems is established, the protein's expression distribution, potential functions in non-sensory tissues, and its relevance to other pathologies (e.g., cancer, neurological disorders) remain poorly defined. Previous studies were limited to specific tissues or lacked a body-wide overview, largely due to a scarcity of validated antibodies for immunohistochemistry (IHC).

2. Methodology

The study leveraged the Human Protein Atlas (HPA) consortium resources to generate a comprehensive, multi-omics expression map of WHRN. The methodology integrated three distinct data layers:

• Transcriptomics (Bulk RNA): Analyzed normalized transcript per million (nTPM) values from two complementary datasets: the internally generated HPA dataset and the Genotype-Tissue Expression (GTEx) dataset. This covered 51 human tissues across 15 organ systems.
• Transcriptomics (Single-Cell RNA): Examined scRNA-seq data from 34 datasets encompassing 154 distinct cell types to resolve tissue-level expression down to specific cell populations.
• Proteomics (Immunohistochemistry): Validated RNA findings using antibody-based protein expression data.
  • Antibody: A polyclonal rabbit IgG antibody (CAB080582 / 25881-1-AP) was rigorously validated according to IWGAV guidelines.
  • Samples: IHC was performed on Tissue Microarrays (TMAs) containing:
    • 45 normal human tissue types (3 cores per tissue).
    • 20 common cancer types (2 cores per sample, up to 12 patients per type).
    • Specialized retina tissue (2 cores).
  • Scoring: Manual annotation by three experts using a four-level scale (Not detected, Low, Medium, High) based on staining intensity and localization.
• Cell Line Analysis: RNA expression levels were analyzed across a large panel of human cancer and non-cancer cell lines included in the HPA database.

3. Key Contributions

• First Body-Wide Map: This study provides the first comprehensive, single-cell-resolution expression landscape of WHRN across the entire human body.
• Data Integration: It successfully correlates bulk RNA, single-cell RNA, and protein-level data, confirming that transcript levels generally translate to protein expression with cell-type specificity.
• Resource Expansion: The data has been integrated into HPA version 25, making high-resolution histological images and expression data publicly available for the research community.
• Model Identification: It identifies specific human cell lines (including widely used lines like HEK293, HeLa, and MCF-7) that express endogenous WHRN, offering practical in vitro models for future mechanistic studies.

4. Key Results

A. Tissue and Organ Distribution

• Ubiquity: WHRN was detected in 49 out of 51 tissues analyzed.
• High Expression: Highest levels were found in endocrine organs (adrenal, thyroid, pituitary), reproductive tissues (testis, epididymis), and the nervous system.
• Low Expression: Consistently low levels were observed in muscle tissues, vascular tissues, and squamous epithelia (e.g., skin, esophagus).
• Sensory Tissues: High expression confirmed in the retina (photoreceptors); inner ear tissues were not represented in the datasets.

B. Cell-Type Specific Enrichment (scRNA-seq)

The broad tissue distribution is driven by enrichment in specific cell types rather than uniform expression:

• Endocrine Cells: Adrenal cortex cells and various pituitary hormone-producing cells (gonadotrophs, thyrotrophs, etc.) showed the strongest expression.
• Ciliated Cells: High expression in ciliated epithelial cells across the brain (choroid plexus), respiratory tract, and reproductive tract.
• Reproductive Cells: Markedly elevated in male germ cells (spermatids) and Sertoli cells; glandular and ciliated cells in female reproductive tissues.
• Immune Cells: Moderate expression in plasma cells and lymphocytes, explaining intermediate levels in lymphoid tissues.
• Neural Cells: Enrichment in glial cells (oligodendrocytes) and ciliated cells of the choroid plexus, in addition to retinal photoreceptors.

C. Protein Localization

• Pattern: IHC confirmed cytoplasmic staining with varying intensities, often combined with membranous positivity.
• Specificity: Staining patterns in normal tissues aligned with transcriptomic data. Notably, strong luminal membrane staining was observed in placenta, salivary ducts, and gall bladder epithelium.
• Cancer Tissues: Expression in tumors generally mirrored corresponding normal tissues (no global overexpression). However, lymphoma showed high expression in 10/11 patients. High-to-medium expression was also seen in colorectal, stomach, and thyroid cancers.

D. Cell Line Models

• High Expression: Myeloma cell lines showed the highest RNA levels (nTPM > 65), followed by lymphoma, skin cancer, and rhabdoid cell lines.
• Standard Models: Endogenous WHRN was detected in standard laboratory lines including HEK293, HeLa, MCF-7, PC-3, and RPMI-8226, validating their utility for functional studies.

5. Significance and Implications

• Beyond Sensory Systems: The findings suggest WHRN plays a broader physiological role in membrane-cytoskeletal organization, particularly in ciliated cells and specialized epithelia involved in secretion and absorption.
• Endocrine Function: The strong enrichment in endocrine cells supports hypotheses linking WHRN to hormone secretion pathways and clinical reports connecting it to thyroid disorders (e.g., Hashimoto's thyroiditis).
• Neurological Relevance: The presence of WHRN in oligodendrocytes and its association with PDZ domains (synaptic scaffolding) supports emerging links between Usher syndrome proteins and neurological/psychiatric conditions (e.g., bipolar disorder, epilepsy).
• Cancer Biology: While not universally overexpressed, the specific upregulation in lymphomas and gastrointestinal cancers suggests a potential role in tumor biology or as a biomarker, warranting further investigation in larger cohorts.
• Future Research: By establishing a reference map and identifying endogenous-expressing cell lines, this work removes a major barrier to studying WHRN mechanisms outside of hearing and vision, facilitating research into its role in ciliopathies, endocrine disorders, and cancer.